MMJ Phytotech’s $0.33 Share Price is One to Watch

Though MMJ Phytotech Limited [ASX:MMJ]’s share price has been pretty stagnant recently, its media attention hasn’t wavered.

Previously, two separate companies — MMJ and Phytotech — merged in 2015; aligning strategies and asset portfolios were an impetus for the marriage.

As a global cannabis investment company, Phytotech Therapeutics focused on developing and commercialising cannabis-based therapeutic products alongside research and development.

But with Canada to legalisation of recreational cannabis set to occur in only a few months’ time, MMJ is eager to secure the entire cannabis chain.

MMJ’s plan of attack…through investment

Setting the Phytotech business aside for the time being, MMJ is now focusing their efforts into:

Actively managing a portfolio of minority investments…which is expected to generate synergies and growth opportunities that could not be captured by PTL [Phytotech] as a standalone research & development company.

They want to be part (and have a part) in every step of the process.

MMJ has secured shareholdings in multiple cannabis-related entities. These include Weed Me Inc (a cultivation company), and Fire & Flower Inc (a cannabis retail store chain).

A little closer to home is their holdings in a leading online portal for medical cannabis in Australia. They also have holdings in companies seeking to broaden the licencing of cannabis across Aussie soil.

But that’s not even the best part…

Free Report: Discover four red hot ASX profit plays for 2018. Read Now.

July moves

On 2 July, MMJ announced on the ASX that Phytotech Therapeutics invested CA$5 million for 6.9% basic shareholding in MediPharm Labs Inc.

MediPharm owns Canada’s largest medicinal cannabis oil production facility, processing over 100,000kg of dry cannabis each year. They’re an Access to Cannabis for Medical Purposes Regulations Licensed Producer and expect a sales licence once recreational cannabis is officially legalised.

Their use of innovative extraction technologies makes their products superior. They are in line to seriously capitalise on the growing Canadian medical cannabis oil market.

That’s a smart play by MMJ.

They also have comfortable holdings in Canada’s cannabis supply chain, obtaining over a third of the shares of Harvest One Cannabis Inc. This company’s shareholders ‘have significant exposure to the entire cannabis value chain’.

Today, MMJ released an announcement regarding the appointment of a new CEO for Harvest One. Grant Froese has worked in information technology, supply chain, ecommerce businesses and marketing. He is sure to become a valuable asset to the Harvest One team.

Worth Watching

It’s slow progress at the moment for MMJ, but there are a heap of signs pointing toward major future potential.

They plan to rename the company to MMJ Group Holdings to reflect their new goal of banking on the entire cannabis economy.


Ryan Clarkson-Ledward,

For Money Morning

PS: While this stock may be in too much of a grey-area to jump on, there are stocks that have proven their potential. Check out our report on ‘The Four Best ASX Stocks’ to help strengthen your investment portfolio.

Money Morning is Australia’s most outspoken financial news service. Your Money Morning editorial team are not afraid to tell it like it is. From calling out politicians to taking on the housing industry, our aim is to cut through the hype and BS to help you make sense of the stories that make a difference to your wealth. Whether you agree with us or not, you’ll find our common-sense, thought provoking arguments well worth a read.

Money Morning Australia is published by Fat Tail Investment Research, an independent financial publisher based in Melbourne, Australia. As an Australian financial services license holder we are subject to the regulations and laws of Corporations Act and Financial Services Act.

Money Morning Australia